Dazzling green luminescent and biocompatible Tb3+-activated lanthanum tungstate nanophosphors for group-III evaluation of latent fingerprints and anticancer applications

Dazzling green emission exhibiting Tb3+ ions doped lanthanum tungstate (LWO) nanophosphors were synthesized by a facile hydrothermally assisted solid-state reaction method. The nanophosphors were determined to have an orthorhombic structure using XRD analysis. In the optimized Tb3+: LWO nanophosphor, FE-SEM revealed aggregated non-uniform nanorods. TEM, FTIR, and XPS studies were performed to examine the material properties. A predominant excitation band was recorded at 488 nm (7F6-*5D4) for the Tb3+ doped LWO nanophosphors, along with a moderately intense excitation band at 378 nm (7F6-*5G6). Ravishing green emission at 544 nm (5D4-*7F5) was obtained from Tb3+ ions containing LWO nanophosphors under excitation at 378 nm and 488 nm. We improved the green emission intensity by increasing the Tb3+ ion concentration up to 14 mol%, which was reduced after 14 mol% due to concentration quenching. The energy-level diagram shows the green radiative transition pathway. The CIE coordinates and color purity were computed for Tb3+: LWO nanophosphors from their emission profiles, and the evaluated coordinates were centralized in the strong green region. A high color purity of 90.1% was obtained appreciably from the optimized Tb3+: LWO nanophosphor. The lifetime of the green emission transition was systematically evaluated based on decay dynamics. The visualization of fingerprints was examined using the optimized green phosphor with an in-depth analysis of the Group-III level details. The non-cytotoxicity of Tb3+ (14 mol%): LWO nanophosphor was confirmed in normal WI-38 lung fibroblast cells. Moreover, these phosphors exhibited strong cytotoxicity against human breast cancer cells of MCF-7. From these results, the synthesized Tb3+ (14 mol%): LWO non-cytotoxic nanophosphor material is considered the best green luminescent material for latent fingerprints in forensic investigation, photonic and anticancer applications.(c) 2023 Elsevier B.V. All rights reserved.